232 related articles for article (PubMed ID: 6791551)
1. Prothrombin complex concentrates: clinical use.
Menache D
Ann N Y Acad Sci; 1981; 370():747-56. PubMed ID: 6791551
[No Abstract] [Full Text] [Related]
2. Prothrombin complex concentrates for clinical use.
Chandra S; Brummelhuis HG
Vox Sang; 1981; 41(5-6):257-73. PubMed ID: 6798760
[TBL] [Abstract][Full Text] [Related]
3. Prothrombin complex concentrates: preparation, properties, and clinical uses.
White GC; Lundblad RL; Kingdon HS
Curr Top Hematol; 1979; 2():203-44. PubMed ID: 318075
[No Abstract] [Full Text] [Related]
4. Editorial: Factor VIII inhibitors.
Deykin D
N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
[No Abstract] [Full Text] [Related]
5. Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.
Quinlan DJ; Eikelboom JW; Weitz JI
Circulation; 2013 Sep; 128(11):1179-81. PubMed ID: 23935012
[No Abstract] [Full Text] [Related]
6. Activated prothrombin concentrate for patients with factor VIII inhibitors.
Kurczynski EM; Penner JA
N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
[No Abstract] [Full Text] [Related]
7. Factor IX complex.
Aronson DL
Semin Thromb Hemost; 1979; 6(1):28-43. PubMed ID: 390713
[No Abstract] [Full Text] [Related]
8. Use of prothrombin complex concentrates in anticoagulation.
van Veen SQ; Strengers PF
Am J Hematol; 2008 Apr; 83(4):344-5. PubMed ID: 18213649
[No Abstract] [Full Text] [Related]
9. Clinical use of human prothrombin complexes.
Tullis JL; Melin M; Jurigian P
N Engl J Med; 1965 Sep; 273(13):667-74. PubMed ID: 5827030
[No Abstract] [Full Text] [Related]
10. Properties of commercial factor IX concentrates.
Coan MH; Fournel MA; Mozen MM
Ann N Y Acad Sci; 1981; 370():731-46. PubMed ID: 6168231
[No Abstract] [Full Text] [Related]
11. Preliminary characterization of a "factor VIII bypassing coagulant".
Aronson DL; Bagley J
Ann N Y Acad Sci; 1981; 370():291-302. PubMed ID: 6791547
[No Abstract] [Full Text] [Related]
12. Human prothrombin complex.
N Engl J Med; 1965 Sep; 273(13):715-6. PubMed ID: 5827038
[No Abstract] [Full Text] [Related]
13. Prothrombal: a new concentrate of human prothrombin complex for clinical use.
Bruning PF; Loeliger EA
Br J Haematol; 1971 Oct; 21(4):377-98. PubMed ID: 5001176
[No Abstract] [Full Text] [Related]
14. ACP Journal Club. 4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal.
Lang E
Ann Intern Med; 2014 Apr; 160(8):JC6. PubMed ID: 24733223
[No Abstract] [Full Text] [Related]
15. Treatment of hemophilia B with a new clotting-factor concentrate.
Hoag MS; Johnson FF; Robinson JA; Aggeler PM
N Engl J Med; 1969 Mar; 280(11):581-6. PubMed ID: 5764825
[No Abstract] [Full Text] [Related]
16. A therapeutic concentrate of coagulation factors II, IX and X from citrated, factor VIII-depleted plasma.
Middleton SM; Bennett IH; Smith JK
Vox Sang; 1973 May; 24(5):441-56. PubMed ID: 4691239
[No Abstract] [Full Text] [Related]
17. Management of Christmas disease and Stuart-Prower deficiency with a prothrombin-complex concentrate (factors II, VII, IX, X).
Tullis JL; Melin M
Bibl Haematol; 1968; 29():1134-9. PubMed ID: 5700309
[No Abstract] [Full Text] [Related]
18. [The P.P.S.B. coagulant fraction].
Soulier JP; Steinbuch M
Nouv Presse Med; 1975 Oct; 4(36):2581-4. PubMed ID: 812061
[No Abstract] [Full Text] [Related]
19. [Clinical experience with the PPSB fraction in surgery].
Frick U
Zentralbl Chir; 1972 Feb; 97(5):150-3. PubMed ID: 5020589
[No Abstract] [Full Text] [Related]
20. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).
O'Leary DS; Ruymann FB; Conrad ME
J Lab Clin Med; 1971 Jan; 77(1):23-32. PubMed ID: 5540427
[No Abstract] [Full Text] [Related]
[Next] [New Search]
